Floatz logo

ADVICOR COMPONENT NIACIN

Polycystic Ovary Syndrome

Hull University Teaching Hospitals NHS TrustSmall moleculePhase 4 / ApprovedDormant
B
60/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
52/ 100
Competitive Position
73/ 100

Competitive context

66 Active assets in the Polycystic Ovary Syndrome cohort.

Asset / SponsorPhaseRating
Hcg
Eman Basuni Ebrahim Mowad
Phase 4BBB
Semaglutide
Methodist Health System
Phase 4BBB
Liraglutide
Peking University Third Hospital
Phase 4BBB
FOLLITROPIN BETA
Universitair Ziekenhuis Brussel
Phase 4BBB
Drospirenone
Ege University
Phase 4BBB

View all 50 →

Same molecule, other indications

ADVICOR COMPONENT NIACIN is also rated in:

inherited lipid metabolism disorderDormant
BBB
Indicative ·
73 / 100
View asset →
coronary artery disorderDormant
BBB
Indicative ·
73 / 100
View asset →
stroke disorderDormant
BB
Indicative ·
71 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →